Background & Aims Noninvasive and accurate methods are needed to identify patients with
clinically significant portal hypertension (CSPH). We investigated the ability of deep …

Portal hypertension is the cause of the clinical complications associated with cirrhosis. The
primary complications of portal hypertension are ascites, acute variceal bleed, and hepatic …

Background The value of CT in assessment of clinically significant portal hypertension
(CSPH) has not been well determined. Purpose To evaluate the performance of CT features …

Clinically significant portal hypertension (CSPH) is associated with an incremental risk of
esophageal varices and overt clinical decompensations. However, hepatic venous pressure …

The hepatic venous pressure gradient (HVPG) is the gold standard for cirrhotic portal
hypertension (PHT), but it is invasive and specialized. Alternative non-invasive techniques …

Portal hypertension is a complex medical condition characterized by elevated blood
pressure in the portal venous system. The conventional diagnosis of such disease often …

Background Although measurement of the hepatic venous pressure gradient (HVPG) is the
current reference standard for obtaining portal venous pressures, several noninvasive …

Purpose To develop and validate a computational model for estimating hepatic venous
pressure gradient (HVPG) based on CT angiographic images, termed virtual HVPG, to …

Background Currently, the hepatic venous pressure gradient (HVPG) remains the reference
standard for diagnosis of clinically significant portal hypertension (CSPH) but is limited by its …

Background & Aims In individuals with compensated advanced chronic liver disease
(cACLD), the severity of portal hypertension (PH) determines the risk of decompensation …